ILMN – illumina, inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day ILMN SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
ILMN – illumina, inc. (US:NASDAQ)
DELAYED
$ usd
ILMN
SPY
QQQ
SPX
ILMN – illumina, inc. (US:NASDAQ)
DELAYED
$ usd
ILMN SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

Stock Stats
Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
Metagenomics Market Size, Share & Trends Analysis Report 2024-2030: Emergence of New Fields in Genomics that Complement Metagenomics Fueling Expansion [Yahoo! Finance]
GRAIL to Host Capital Markets Day [Yahoo! Finance]
GRAIL to Host Capital Markets Day
Illumina, Inc. (NASDAQ: ILMN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Rapid Growth of Biotechnology and Pharmacogenomics is Stimulating the Growth of the Global Personalized Medicines Market; says TNR, The Niche Research [Yahoo! Finance]
Genomics Market to be Worth $70.52 Billion by 2031--Exclusive Report by Meticulous Research® [Yahoo! Finance]
Illumina, Inc. (NASDAQ: ILMN) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $170.00 price target on the stock.
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL [Yahoo! Finance]
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
Form 4 ILLUMINA, INC. For: May 06 Filed by: Dhingra Ankur
Form 4 ILLUMINA, INC. For: May 06 Filed by: Wedel Christensen Jakob
Form 8-K/A ILLUMINA, INC. For: May 03
Form 10-Q ILLUMINA, INC. For: Mar 31
Form 8-K ILLUMINA, INC. For: May 02
Form 3 ILLUMINA, INC. For: Apr 15 Filed by: Dhingra Ankur
Form 3 ILLUMINA, INC. For: Apr 15 Filed by: Wedel Christensen Jakob
Form 8-K ILLUMINA, INC. For: Apr 12
Form 4 ILLUMINA, INC. For: Apr 05 Filed by: Rollins Carissa
Show more